This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Curevac Ag, Curevac Se. Active years: 2019-2024.
Location History:
- München, DE (2019)
- Munich, DE (2021)
Company Filing History:
Years Active: 2019-2024
Title: The Innovative Work of Jan C. Schmollinger in the Field of Vaccination Technology
Introduction
Jan C. Schmollinger, a prominent inventor based in Munich, Germany, has made significant contributions to the field of vaccination technology. With a total of three patents to his name, his work focuses on enhancing vaccine efficacy through innovative combinations with OX40 agonists.
Latest Patents
Among his latest inventions is a groundbreaking patent that details a vaccine/agonist combination, which includes an RNA vaccine. This vaccine comprises at least one RNA molecule featuring an open reading frame (ORF) that codes for an antigen. The invention claims to provide not only a pharmaceutical composition but also a kit that contains the components necessary for this vaccine/agonist combination. It particularly aims to address tumor or cancer diseases as well as infectious diseases, highlighting a promising avenue for therapeutic applications through the integration of RNA vaccines and OX40 agonists.
Career Highlights
Jan C. Schmollinger has accumulated valuable experience working in reputable companies within the vaccine development sector, notably CureVac AG and CureVac SE. His contributions at these firms have played a pivotal role in advancing the technology and approaches used in vaccine formulation, achieving significant milestones in the field.
Collaborations
Throughout his career, Schmollinger has collaborated with distinguished professionals, including Mariola Fotin-Mleczek and Karl-Josef Kallen. These partnerships have fostered an environment of innovation, facilitating the progression of research and development in vaccination strategies and therapies.
Conclusion
Jan C. Schmollinger exemplifies the spirit of innovation within the vaccination landscape. His patents not only showcase his ingenuity but also present new possibilities in the prevention and treatment of serious health conditions. As research continues to evolve, contributions like those of Schmollinger serve as a cornerstone for future developments in medical science.